CN103800449B - 一种治疗阴虚热盛证2型糖尿病的中药组合物 - Google Patents
一种治疗阴虚热盛证2型糖尿病的中药组合物 Download PDFInfo
- Publication number
- CN103800449B CN103800449B CN201410082673.6A CN201410082673A CN103800449B CN 103800449 B CN103800449 B CN 103800449B CN 201410082673 A CN201410082673 A CN 201410082673A CN 103800449 B CN103800449 B CN 103800449B
- Authority
- CN
- China
- Prior art keywords
- diabetes
- medicine
- yin
- chinese medicine
- largeleaf gymnema
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 76
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title claims abstract description 16
- 241000037488 Coccoloba pubescens Species 0.000 claims abstract description 43
- 241000208251 Gymnema Species 0.000 claims abstract description 43
- 239000004615 ingredient Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 34
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 23
- 239000008103 glucose Substances 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 22
- 150000001720 carbohydrates Chemical class 0.000 abstract description 18
- 235000014633 carbohydrates Nutrition 0.000 abstract description 18
- 241000699670 Mus sp. Species 0.000 abstract description 14
- 230000001976 improved effect Effects 0.000 abstract description 9
- 238000002474 experimental method Methods 0.000 abstract description 7
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 34
- 241000700159 Rattus Species 0.000 description 27
- 239000012567 medical material Substances 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 230000000694 effects Effects 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000463 material Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000000287 crude extract Substances 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 229960004329 metformin hydrochloride Drugs 0.000 description 5
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 5
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 5
- 239000012453 solvate Substances 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000000638 solvent extraction Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 201000002282 venous insufficiency Diseases 0.000 description 4
- 241000345998 Calamus manan Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010241 blood sampling Methods 0.000 description 3
- 235000020965 cold beverage Nutrition 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 235000012950 rattan cane Nutrition 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241001492220 Echovirus E2 Species 0.000 description 1
- 208000023329 Gun shot wound Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 206010054805 Macroangiopathy Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 241001058321 Taraxacum sinicum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410082673.6A CN103800449B (zh) | 2013-12-24 | 2014-03-07 | 一种治疗阴虚热盛证2型糖尿病的中药组合物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013107313962 | 2013-12-24 | ||
CN201310731396.2 | 2013-12-24 | ||
CN201310731396 | 2013-12-24 | ||
CN201410082673.6A CN103800449B (zh) | 2013-12-24 | 2014-03-07 | 一种治疗阴虚热盛证2型糖尿病的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103800449A CN103800449A (zh) | 2014-05-21 |
CN103800449B true CN103800449B (zh) | 2016-04-27 |
Family
ID=50698144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410082673.6A Active CN103800449B (zh) | 2013-12-24 | 2014-03-07 | 一种治疗阴虚热盛证2型糖尿病的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103800449B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106306817A (zh) * | 2015-07-08 | 2017-01-11 | 李凤军 | 一种防治糖尿病的保健食品组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1099630A (zh) * | 1993-08-31 | 1995-03-08 | 天津市第三中心医院 | 胰活散冲剂 |
CN101537102A (zh) * | 2009-04-10 | 2009-09-23 | 陈德良 | 一种治疗糖尿病的药食两用组合物及其制备方法 |
CN101999668A (zh) * | 2010-10-11 | 2011-04-06 | 孙羽蒙 | 一种用于治疗糖尿病的组方 |
-
2014
- 2014-03-07 CN CN201410082673.6A patent/CN103800449B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1099630A (zh) * | 1993-08-31 | 1995-03-08 | 天津市第三中心医院 | 胰活散冲剂 |
CN101537102A (zh) * | 2009-04-10 | 2009-09-23 | 陈德良 | 一种治疗糖尿病的药食两用组合物及其制备方法 |
CN101999668A (zh) * | 2010-10-11 | 2011-04-06 | 孙羽蒙 | 一种用于治疗糖尿病的组方 |
Non-Patent Citations (2)
Title |
---|
"中医药治疗糖尿病文献综述(二)";周安方;《湖北中医杂志》;19801027(第5期);第47-51页 * |
广西匙羹藤茎降血糖活性部位的研究;梁洁等;《中国实验方剂学杂志》;20070228;第13卷(第2期);第29-31页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103800449A (zh) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100363022C (zh) | 一种具有免疫调节作用的药物组合物及其制备方法 | |
CN103990081B (zh) | 一种中药组合物及其在制备治疗婴幼儿黄疸药物中的用途 | |
WO2010135858A1 (zh) | 药物组合物及其在制备药剂中的用途 | |
CN102319357B (zh) | 一种降脂灵分散片及其制备工艺 | |
CN103690582B (zh) | 一种含石斛多糖和苍术硬脂的组合物及其应用 | |
CN101023992B (zh) | 治疗乳腺增生病的药物 | |
CN103223104A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN101020016B (zh) | 治疗骨折和伤筋的药物及其制备方法 | |
CN106362004A (zh) | 一种复方鲜石斛颗粒及其制备方法 | |
CN103800449B (zh) | 一种治疗阴虚热盛证2型糖尿病的中药组合物 | |
CN1686424B (zh) | 一种含有黄芩和柴胡的药物组合物及其制备方法 | |
CN102028834B (zh) | 一种复方龙血竭制剂及其制备方法 | |
CN106535912A (zh) | 控制人体血脂和体重的药物组合物及其应用 | |
CN106581236A (zh) | 一种促进胃动力的药物组合物及其制备方法和应用 | |
CN107648397B (zh) | 一种用于治疗肝肾阴虚型的中药组合物及其制备方法和应用 | |
CN101264241B (zh) | 一种治疗妇科疾病的药物组合物及制备方法 | |
CN103989940A (zh) | 一种治疗糖尿病的中药组合物 | |
CN104337898B (zh) | 一种含郁李仁的治疗痛风的中药组合物 | |
CN113995782B (zh) | 含夏枯草的组合物在制备治疗甲状腺结节的药物中的应用 | |
CN110215474B (zh) | 一种活血化瘀中药组合物及其应用 | |
CN108186821A (zh) | 一种治疗神经性头痛的中药组合物及其制备方法和用途 | |
CN102764301A (zh) | 一种制备小儿柴桂退热颗粒的新工艺 | |
CN102363017A (zh) | 一种用于清热解毒、活血化瘀、利湿化痰的中药组合物及其制备方法 | |
CN108704080B (zh) | 一种治疗肾阴虚型抑郁症的药物及其制备方法 | |
CN107684601B (zh) | 一种能够降血糖的复方颗粒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20140521 Assignee: GUANGXI WUZHOU SANHE PHARMACEUTICAL CO.,LTD. Assignor: GUANGXI INSTITUTE OF CHINESE MEDICINE & PHARMACEUTICAL SCIENCE Contract record no.: X2023980044815 Denomination of invention: A traditional Chinese medicine composition for treating type 2 diabetes with yin deficiency and heat excess syndrome Granted publication date: 20160427 License type: Common License Record date: 20231031 |
|
EE01 | Entry into force of recordation of patent licensing contract |